510(k) K972986

ACCURUN 140 RUBELLA IGG POSITIVE CONTROL by Boston Biomedica, Inc. — Product Code MJX

K972986 is an FDA 510(k) premarket notification submitted by Boston Biomedica, Inc. for the device "ACCURUN 140 RUBELLA IGG POSITIVE CONTROL". The FDA issued a decision of Substantially Equivalent on Oct 8, 1997. The device falls under product code MJX (Kit, Serological, Positive Control), a Class I device regulated under 21 CFR 862.1660. Boston Biomedica, Inc. has 11 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Oct 8, 1997
Date Received
Aug 11, 1997
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Kit, Serological, Positive Control
Device Class
Class I
Regulation Number
862.1660
Review Panel
MI
Submission Type
510(k) Exempt

Need the full FDA record for Boston Biomedica, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K972986. Report a data issue: hello@regdatalab.com.